“Galectin-3 As a Potential Marker of Myocardial Hypertrophy in Essential Hypertension in Individuals With Polymorphic AT1R Genotypes”. Biomedical Research and Therapy, vol. 5, no. 8, Aug. 2018, pp. 2633-44, https://doi.org/10.15419/bmrat.v5i8.471.